Suppr超能文献

无导线经心外膜左心室心尖部起搏:动物研究。

Leadless epicardial pacing at the left ventricular apex: an animal study.

机构信息

Pediatric Heart Center, Justus-Liebig University Giessen, Feulgenstrasse 10-12, 35385 Gießen, Germany.

Department of Pediatric Cardiology, Intensive Care Medicine and Neonatology, University Medical Center, Georg-August-University Göttingen, Robert-Koch Str. 40, 37075 Göttingen, Germany.

出版信息

Europace. 2023 Oct 5;25(10). doi: 10.1093/europace/euad303.

Abstract

AIMS

State-of-the-art pacemaker implantation technique in infants and small children consists of pace/sense electrodes attached to the epicardium and a pulse generator in the abdominal wall with a significant rate of dysfunction during growth, mostly attributable to lead failure. In order to overcome lead-related problems, feasibility of epicardial implantation of a leadless pacemaker at the left ventricular apex in a growing animal model was studied.

METHODS AND RESULTS

Ten lambs (median body weight 26.8 kg) underwent epicardial implantation of a Micra transcatheter pacing system (TPS) pacemaker (Medtronic Inc., Minneapolis, USA). Using a subxyphoid access, the Micra was introduced through a short, thick-walled tube to increase tissue contact and to prevent tilting from the epicardial surface. The Micra's proprietary delivery system was firmly pressed against the heart, while the Micra was pushed forward out of the sheath allowing the tines to stick into the left ventricular apical epimyocardium. Pacemakers were programmed to VVI 30/min mode. Pacemaker function and integrity was followed for 4 months after implantation. After implantation, median intrinsic R-wave amplitude was 5 mV [interquartile range (IQR) 2.8-7.5], and median pacing impedance was 2235 Ω (IQR 1725-2500), while the median pacing threshold was 2.13 V (IQR 1.25-2.9) at 0.24 ms. During follow-up, 6/10 animals had a significant increase in pacing threshold with loss of capture at maximum output at 0.24 ms in 2/10 animals. After 4 months, median R-wave amplitude had dropped to 2.25 mV (IQR 1.2-3.6), median pacing impedance had decreased to 595 Ω (IQR 575-645), and median pacing threshold had increased to 3.3 V (IQR 1.8-4.5) at 0.24 ms. Explantation of one device revealed deep penetration of the Micra device into the myocardium.

CONCLUSION

Short-term results after epicardial implantation of the Micra TPS at the left ventricular apex in lambs were satisfying. During mid-term follow-up, however, pacing thresholds increased, resulting in loss of capture in 2/10 animals. Penetration of one device into the myocardium was of concern. The concept of epicardial leadless pacing seems very attractive, and the current shape of the Micra TPS makes the device unsuitable for epicardial placement in growing organisms.

摘要

目的

目前,婴儿和幼儿的先进起搏器植入技术包括将起搏/感知电极附着于心外膜和腹壁中的脉冲发生器,但在生长过程中,其功能障碍发生率很高,主要归因于导线故障。为了克服与导线相关的问题,研究了在生长动物模型中经心外膜植入无导线起搏器于左心室心尖部的可行性。

方法和结果

10 只羔羊(中位体重 26.8kg)接受了经Micra 经导管起搏系统(TPS)起搏器(美敦力公司,明尼苏达州,美国)的心外膜植入。使用剑突下入路,将 Micra 通过一个短而厚壁的导管引入,以增加组织接触并防止从心外膜表面倾斜。Micra 的专有输送系统被紧紧地压在心脏上,同时将 Micra 从鞘中推出,使叉齿插入左心室心尖部的心外膜。将起搏器程控为 VVI 30/min 模式。植入后 4 个月随访起搏器功能和完整性。植入后,中位固有 R 波振幅为 5mV[四分位间距(IQR)2.8-7.5],中位起搏阻抗为 2235Ω(IQR 1725-2500),而中位起搏阈值为 2.13V(IQR 1.25-2.9)在 0.24ms 时。在随访期间,6/10 只动物的起搏阈值显著增加,在 2/10 只动物中,最大输出时的捕获丢失。4 个月后,中位 R 波振幅降至 2.25mV(IQR 1.2-3.6),中位起搏阻抗降至 595Ω(IQR 575-645),中位起搏阈值增至 3.3V(IQR 1.8-4.5)在 0.24ms 时。一个装置的解剖显示 Micra 装置深深穿透了心肌。

结论

在羔羊左心室心尖部经心外膜植入 Micra TPS 的短期结果令人满意。然而,在中期随访期间,起搏阈值增加,导致 2/10 只动物的捕获丢失。一个装置穿透心肌令人担忧。经心外膜无导线起搏的概念非常有吸引力,而目前的 Micra TPS 形状使该装置不适合在生长中的生物体中进行心外膜放置。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71cc/10616611/79e8831be823/euad303f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验